Moreover, glioma cells that stably overexpress SOD and CAT exhibit high resistance to TMZ, enhanced tumorsphere formation, and poor prognosis [25,26], and TMZ-resistant glioma cells display increased expression of CAT, SOD2, and BMI1, a protein associated with stemness and therapy resistance [27]. This evidence concerns the gene SOD2 and central nervous system cancer.